170 related articles for article (PubMed ID: 37941595)
1. Knowledge and Attitude of Inflammatory Bowel Disease Patients Toward Colorectal Cancer Risk, Its Management, and the Role of Healthcare Providers: A Cross-Sectional Study in the UK.
Khan F; Norton C; Czuber-Dochan W
Crohns Colitis 360; 2023 Oct; 5(4):otad067. PubMed ID: 37941595
[TBL] [Abstract][Full Text] [Related]
2. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
3. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
5. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
6. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
Thomas T; Nair P; Dronfield MW; Mayberry JF
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
[TBL] [Abstract][Full Text] [Related]
7. Colorectal Cancer in Inflammatory Bowel Disease.
Nebbia M; Yassin NA; Spinelli A
Clin Colon Rectal Surg; 2020 Sep; 33(5):305-317. PubMed ID: 32968366
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Disease-Associated Colorectal Cancer Epidemiology and Outcomes: An English Population-Based Study.
Birch RJ; Burr N; Subramanian V; Tiernan JP; Hull MA; Finan P; Rose A; Rutter M; Valori R; Downing A; Morris EJA
Am J Gastroenterol; 2022 Nov; 117(11):1858-1870. PubMed ID: 36327438
[TBL] [Abstract][Full Text] [Related]
9. Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
Wijnands AM; Te Groen M; Peters Y; Kaptein AA; Oldenburg B; Hoentjen F; Lutgens MWMD
Inflamm Bowel Dis; 2022 Jul; 28(7):1053-1060. PubMed ID: 34487155
[TBL] [Abstract][Full Text] [Related]
10. Awareness of Stomach and Colorectal Cancer Risk Factors, Symptoms and Time Taken to Seek Medical Help Among Public Attending Primary Care Setting in Muscat Governorate, Oman.
Al-Azri M; Al-Kindi J; Al-Harthi T; Al-Dahri M; Panchatcharam SM; Al-Maniri A
J Cancer Educ; 2019 Jun; 34(3):423-434. PubMed ID: 28782080
[TBL] [Abstract][Full Text] [Related]
11. Current management of inflammatory bowel disease and colorectal cancer.
Mattar MC; Lough D; Pishvaian MJ; Charabaty A
Gastrointest Cancer Res; 2011 Mar; 4(2):53-61. PubMed ID: 21673876
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
Lynch HT; Brand RE; Locker GY
Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
[TBL] [Abstract][Full Text] [Related]
13. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance.
Wang ZH; Fang JY
Gastrointest Tumors; 2014 Aug; 1(3):146-54. PubMed ID: 26674110
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
18. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
20. Strategies for detecting colon cancer in patients with inflammatory bowel disease.
Bye WA; Nguyen TM; Parker CE; Jairath V; East JE
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD000279. PubMed ID: 28922695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
